FDA Notifies Applicants of Intent to Require Sweeping Changes to Labeling for IR Opioid Analgesics and Entire Class of Prescription Opioids March 24, 2016
President signs The Food and Drug Administration Safety and Innovation Act: Summary of certain key provisions July 12, 2012